These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators. Grundmann M; Bender E; Schamberger J; Eitner F Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942 [TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of free fatty acid receptors FFAR2 and FFAR3 in the domestic cat. Yamamoto I; Kawasumi K; Ohkusu-Tsukada K; Arai T Vet Med Sci; 2021 Jan; 7(1):77-85. PubMed ID: 32929853 [TBL] [Abstract][Full Text] [Related]
29. Free fatty acid receptors as therapeutic targets for the treatment of diabetes. Ichimura A; Hasegawa S; Kasubuchi M; Kimura I Front Pharmacol; 2014; 5():236. PubMed ID: 25414667 [TBL] [Abstract][Full Text] [Related]
30. Enhanced expression of the urokinase-type plasminogen activator gene and reduced colony formation in soft agar by ectopic expression of PU.1 in HT1080 human fibrosarcoma cells. Kondoh N; Yamada T; Kihara-Negishi F; Yamamoto M; Oikawa T Br J Cancer; 1998 Sep; 78(6):718-23. PubMed ID: 9743289 [TBL] [Abstract][Full Text] [Related]
31. Dietary fatty acid content influences the expression of genes involved in the lipid turnover and inflammation in mouse colon and spleen. Mosińska P; Tarasiuk A; Fabisiak A; Krajewska J; Niewinna K; Bartoszek A; Binienda A; Sałaga M; Fichna J Pharmacol Rep; 2019 Oct; 71(5):899-908. PubMed ID: 31421543 [TBL] [Abstract][Full Text] [Related]
32. Resveratrol induces MMP-9 and cell migration via the p38 kinase and PI-3K pathways in HT1080 human fibrosarcoma cells. Gweon EJ; Kim SJ Oncol Rep; 2013 Feb; 29(2):826-34. PubMed ID: 23229870 [TBL] [Abstract][Full Text] [Related]
33. Receptor for hyaluronic acid- mediated motility (RHAMM) regulates HT1080 fibrosarcoma cell proliferation via a β-catenin/c-myc signaling axis. Kouvidi K; Berdiaki A; Tzardi M; Karousou E; Passi A; Nikitovic D; Tzanakakis GN Biochim Biophys Acta; 2016 Apr; 1860(4):814-24. PubMed ID: 26825774 [TBL] [Abstract][Full Text] [Related]
34. For Better or Worse: FFAR1 and FFAR4 Signaling in Cancer and Diabetes. Houthuijzen JM Mol Pharmacol; 2016 Dec; 90(6):738-743. PubMed ID: 27582526 [TBL] [Abstract][Full Text] [Related]
35. FFAR2 antagonizes TLR2- and TLR3-induced lung cancer progression via the inhibition of AMPK-TAK1 signaling axis for the activation of NF-κB. Kim MJ; Kim JY; Shin JH; Kang Y; Lee JS; Son J; Jeong SK; Kim D; Kim DH; Chun E; Lee KY Cell Biosci; 2023 Jun; 13(1):102. PubMed ID: 37287005 [TBL] [Abstract][Full Text] [Related]
36. New frontiers in gut nutrient sensor research: free fatty acid sensing in the gastrointestinal tract. Miyauchi S; Hirasawa A; Ichimura A; Hara T; Tsujimoto G J Pharmacol Sci; 2010; 112(1):19-24. PubMed ID: 20093784 [TBL] [Abstract][Full Text] [Related]
37. Free fatty acid receptors act as nutrient sensors to regulate energy homeostasis. Ichimura A; Hirasawa A; Hara T; Tsujimoto G Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):82-8. PubMed ID: 19460454 [TBL] [Abstract][Full Text] [Related]
38. Free Fatty Acid Receptors as Mediators and Therapeutic Targets in Liver Disease. Secor JD; Fligor SC; Tsikis ST; Yu LJ; Puder M Front Physiol; 2021; 12():656441. PubMed ID: 33897464 [TBL] [Abstract][Full Text] [Related]
39. Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA Minami K; Ueda N; Maeda H; Ishimoto K; Otagaki S; Tsujiuchi T Biochem Biophys Res Commun; 2019 Sep; 517(2):359-363. PubMed ID: 31362892 [TBL] [Abstract][Full Text] [Related]